
25 June @ 1:00 pm – 2:00 pm Europe/Online
APROVALS Webinar Series – Public Session
This is the first session of the APROVALS public webinar series, a programme of collective learning events open to companies participating in the project and to the broader industrial ecosystem.
APROVALS webinars are designed to go beyond individual sandbox sessions: they create a shared space where companies can compare experiences, discuss cross-cutting challenges, and engage with external experts on the topics that matter most to scaling innovative technologies.
Session #1 – Preparing for scale: industrial readiness and infrastructure access
One of the most strategic — and most frequently asked — questions among APROVALS participants: how do you know when you are ready to move from pilot to industrial scale?
This session will explore:
We’ll discuss with:
Rob Kooijmans (Food Safety)
Reza Ranjbar (AartinBio)
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.